![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:ENO1-MCUR1 (FusionGDB2 ID:HG2023TG63933) |
Fusion Gene Summary for ENO1-MCUR1 |
![]() |
Fusion gene information | Fusion gene name: ENO1-MCUR1 | Fusion gene ID: hg2023tg63933 | Hgene | Tgene | Gene symbol | ENO1 | MCUR1 | Gene ID | 2023 | 63933 |
Gene name | enolase 1 | mitochondrial calcium uniporter regulator 1 | |
Synonyms | ENO1L1|HEL-S-17|MPB1|NNE|PPH | C6orf79|CCDC90A|FMP32 | |
Cytomap | ('ENO1')('MCUR1') 1p36.23 | 6p23 | |
Type of gene | protein-coding | protein-coding | |
Description | alpha-enolasec-myc promoter-binding protein-12-phospho-D-glycerate hydro-lyaseMYC promoter-binding protein 1alpha enolase like 1enolase 1, (alpha)enolase-alphaepididymis secretory protein Li 17non-neural enolasephosphopyruvate hydrataseplasminog | mitochondrial calcium uniporter regulator 1MCU regulator 1coiled-coil domain containing 90Acoiled-coil domain-containing protein 90A, mitochondrialepididymis secretory sperm binding protein | |
Modification date | 20200320 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000234590, | ||
Fusion gene scores | * DoF score | 31 X 31 X 10=9610 | 5 X 5 X 2=50 |
# samples | 44 | 5 | |
** MAII score | log2(44/9610*10)=-4.44896100213645 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/50*10)=0 | |
Context | PubMed: ENO1 [Title/Abstract] AND MCUR1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ENO1(8926441)-MCUR1(13788202), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ENO1 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 2005901 |
Hgene | ENO1 | GO:0030308 | negative regulation of cell growth | 10082554 |
Hgene | ENO1 | GO:0045892 | negative regulation of transcription, DNA-templated | 10082554 |
Hgene | ENO1 | GO:0061621 | canonical glycolysis | 29775581 |
Hgene | ENO1 | GO:1903298 | negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway | 15459207 |
Hgene | ENO1 | GO:2001171 | positive regulation of ATP biosynthetic process | 15459207 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Top |
Fusion Gene ORF analysis for ENO1-MCUR1 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for ENO1-MCUR1 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for ENO1-MCUR1 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:8926441/:13788202) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for ENO1-MCUR1 |
![]() |
Top |
Fusion Gene PPI Analysis for ENO1-MCUR1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ENO1-MCUR1 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ENO1-MCUR1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ENO1 | C0019193 | Hepatitis, Toxic | 2 | CTD_human |
Hgene | ENO1 | C0152013 | Adenocarcinoma of lung (disorder) | 2 | CTD_human |
Hgene | ENO1 | C0860207 | Drug-Induced Liver Disease | 2 | CTD_human |
Hgene | ENO1 | C1262760 | Hepatitis, Drug-Induced | 2 | CTD_human |
Hgene | ENO1 | C3658290 | Drug-Induced Acute Liver Injury | 2 | CTD_human |
Hgene | ENO1 | C4277682 | Chemical and Drug Induced Liver Injury | 2 | CTD_human |
Hgene | ENO1 | C4279912 | Chemically-Induced Liver Toxicity | 2 | CTD_human |
Hgene | ENO1 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | ENO1 | C0001787 | Osteoporosis, Age-Related | 1 | CTD_human |
Hgene | ENO1 | C0002395 | Alzheimer's Disease | 1 | CTD_human |
Hgene | ENO1 | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Hgene | ENO1 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Hgene | ENO1 | C0007097 | Carcinoma | 1 | CTD_human |
Hgene | ENO1 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Hgene | ENO1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Hgene | ENO1 | C0011265 | Presenile dementia | 1 | CTD_human |
Hgene | ENO1 | C0014859 | Esophageal Neoplasms | 1 | CTD_human |
Hgene | ENO1 | C0021364 | Male infertility | 1 | CTD_human |
Hgene | ENO1 | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
Hgene | ENO1 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Hgene | ENO1 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Hgene | ENO1 | C0026640 | Mouth Neoplasms | 1 | CTD_human |
Hgene | ENO1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | ENO1 | C0029408 | Degenerative polyarthritis | 1 | CTD_human |
Hgene | ENO1 | C0029456 | Osteoporosis | 1 | CTD_human |
Hgene | ENO1 | C0029459 | Osteoporosis, Senile | 1 | CTD_human |
Hgene | ENO1 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | ENO1 | C0086743 | Osteoarthrosis Deformans | 1 | CTD_human |
Hgene | ENO1 | C0153381 | Malignant neoplasm of mouth | 1 | CTD_human |
Hgene | ENO1 | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human |
Hgene | ENO1 | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human |
Hgene | ENO1 | C0205643 | Carcinoma, Cribriform | 1 | CTD_human |
Hgene | ENO1 | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human |
Hgene | ENO1 | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human |
Hgene | ENO1 | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
Hgene | ENO1 | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
Hgene | ENO1 | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
Hgene | ENO1 | C0205699 | Carcinomatosis | 1 | CTD_human |
Hgene | ENO1 | C0276496 | Familial Alzheimer Disease (FAD) | 1 | CTD_human |
Hgene | ENO1 | C0494463 | Alzheimer Disease, Late Onset | 1 | CTD_human |
Hgene | ENO1 | C0520459 | Necrotizing Enterocolitis | 1 | CTD_human |
Hgene | ENO1 | C0546126 | Acute Confusional Senile Dementia | 1 | CTD_human |
Hgene | ENO1 | C0546837 | Malignant neoplasm of esophagus | 1 | CTD_human |
Hgene | ENO1 | C0678222 | Breast Carcinoma | 1 | CTD_human |
Hgene | ENO1 | C0750900 | Alzheimer's Disease, Focal Onset | 1 | CTD_human |
Hgene | ENO1 | C0750901 | Alzheimer Disease, Early Onset | 1 | CTD_human |
Hgene | ENO1 | C0751406 | Post-Traumatic Osteoporosis | 1 | CTD_human |
Hgene | ENO1 | C0848676 | Subfertility, Male | 1 | CTD_human |
Hgene | ENO1 | C0917731 | Male sterility | 1 | CTD_human |
Hgene | ENO1 | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
Hgene | ENO1 | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |
Hgene | ENO1 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Hgene | ENO1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | ENO1 | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
Hgene | ENO1 | C2239176 | Liver carcinoma | 1 | CTD_human |
Hgene | ENO1 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |